The most-watched video in our library is a British vlogger taking his parents through a Shanghai hospital because they were waiting on the NHS at home. It is not an outlier in the genre: “China Hospital vs UK NHS (We Took My Dad)” and “I Went to a Hospital in China Because the UK Failed Me” are variations on the same premise. Before taking that premise on trust, it helps to know what the actual UK numbers are. They are public, monthly, and starker than any thumbnail.
The numbers
NHS England publishes referral-to-treatment (RTT) waiting times every month. As of the most recent data:
- The list stands at around 7.3 million incomplete pathways. The Royal College of Surgeons put the January 2026 figure at an estimated 7.31 million; the BMA’s tracker converts this to roughly 6.15 million individual patients, since one person can wait for more than one treatment. Nuffield Trust’s dashboard showed the list just under 7.3 million in mid-2026, drifting slowly down from its peak.
- The median wait is 12.4 weeks — and the 92nd-percentile wait is 38.6 weeks, per NHS England’s May 2026 statistical press notice. The NHS constitution’s standard is 92% of patients treated within 18 weeks; performance remains below it.
- Over 100,000 people have waited more than a year. 104,734 cases had breached 52 weeks in the most recent monthly figures reported from NHS England data.
- Orthopaedics is the worst-affected specialty. Trauma and orthopaedics has the largest waiting list of any specialty — almost 860,000 people as of October 2025, per the King’s Fund, and the British Orthopaedic Association reports around 60,000 T&O patients waiting over a year, up 21% year on year.
That last bullet explains the video genre better than any cultural commentary. The procedures people wait longest for at home — hips, knees, other orthopaedic work — are exactly the planned, price-transparent procedures where China’s costs differ most from Western private rates. The comparisons write themselves: see our hip replacement and knee replacement pages for sourced numbers. A British patient facing a year of pain with a date somewhere beyond it, and a Shanghai or Chengdu hospital quoting a procedure within the fortnight, is a genuine story — the videos did not invent the gap.
The other side of the ledger
The numbers explain the genre; they do not by themselves justify the trip. Three counterweights matter.
First, the NHS comparison is partly a comparison of different things: NHS care is free at the point of use, and the UK alternative to waiting is domestic private treatment — a different trade-off than flying abroad. Second, the NHS does not fund planned treatment outside Europe, so a China trip is self-funded by definition, and standard travel insurance typically excludes both planned treatment and its complications — a gap with real consequences, covered in detail in our insurance guide. Third, a procedure performed 9,000 km from home creates follow-up questions the waiting-list conversation never includes: aftercare, revisions, and what happens when something goes wrong back in the UK. Those logistics — visas, payments, language — are what our guides section is for.
None of this is an argument for or against the NHS, or for or against going to China. It is the context the videos compress into a title card: a 7.3-million-person queue at one end, a quoted procedure date at the other, and a set of risks and costs in between that deserve the same scrutiny as the waits.